New law aims to distance the FDA from the drug industryBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7500.1106-a (Published 12 May 2005) Cite this as: BMJ 2005;330:1106
- Jeanne Lenzer
- New York
Legislation aimed at ending the close relationship between the US Food and Drug Administration and the drug industry was introduced last week in the House of Representatives by Congressman Maurice Hinchey (Democrat) of New York.
The Food and Drug Administration Improvement Act 2005 has been endorsed by the Center for Science in the Public Interest in Washington, DC, a non-profit education and advocacy organisation. Merrill Goozner, director of the centre's integrity in science project, said it was “exactly what is needed to restore public confidence in the FDA.”
The bill includes several provisions aimed at ending financial conflicts of interest. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial